J96.1 J96.9
Conditions
Interventions
Group 1: Control group: established therapy initiation and follow-up according to clinical routine
Group 2: Telemedicine group: established therapy initiation and follow-up according to clinical routi
Sponsors
Universitätsmedizin Essen-Ruhrlandklinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with indication for NIV-initiation due to chronic respiratory insufficiency according to national and international guidelines Patients who are able and willing to provide their data Naive to long-term NIV treatment, NIV therapy no longer than 7 days before inclusion into study Signed informed consent
Exclusion criteria
Exclusion criteria: Inability to comply with planned study procedures or to comply with study protocol requirements. Another life-threatening disease (other than chronic respiratory insufficiency and underlying disease) with estimated survival < 12 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIV-therapy adherence and NIV-associated quality of life by S3-NIV-questionnaire Measured at: - initiation of therapy - after 1 month - after 6 months - after 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| - Generic and disease-specific quality of life - Number of hospitalisation due to deteriorated health state Measured at: - initiation of therapy - after 1 month - after 6 months - after 12 months | — |
Countries
Germany
Contacts
Public ContactChristoph Schöbel
Universitätsmedizin Essen-Ruhrlandklinik
Outcome results
None listed